THE ROLE OF ORAL CONTRACEPTIVE (OCP) USE IN SYMPTOMATIC GALLSTONE DISEASE

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

KARIMIAN S.F.; KHAYAT E.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Tehran University Medical Journal Year:2000 | Volume:58 | Issue:1 Page(s): 32-37

Download Full-Text

Persian Verion

View:

3,004

Download:

Cites:

Information Journal Paper

Title

THE ROLE OF ORAL CONTRACEPTIVE (OCP) USE IN SYMPTOMATIC GALLSTONE DISEASE

Author(s)

KARIMIAN S.F. | KHAYAT E. | Issue Writer Certificate

Keywords

ORAL CONTRACEPTIVESQ4

GALLSTONEQ4

BODY MASS INDEXQ4

HYPERLIPIDEMIAQ4

DIABETESQ2

Abstract

To examine the relation between ORAL CONTRACEPTIVES (OCPs) use, BODY MASS INDEX, parity, familial history of GALLSTONE disease, history of DIABETES, history of HYPERLIPIDEMIA and GALLSTONE disease in women, we have undertaken a case- control study. The study population compromise 80 hospital patients with diagnosed acute GALLSTONE disease as case group and 200 controls who were patients in hospital with no history of GALLSTONE disease.The data were analysed by Chi- square and t-Student test.The results revealed that: The use of OCPs in case group is higher than that of control group. But there is no significanct difference between them. No relation was found between GALLSTONE disease and BODY MASS INDEX, parity, history of DIABETES, familial history of gallastone disease, use of OCPs of different types and duration of use. While there was a significant difference between the two groups regarding history of HYPERLIPIDEMIA (P<0.05). Finally we found no correlation between the history of use, types and duration of use of OCPs and symptomatic GALLSTONE disease. There was no indication of any interaction between oral contraceptive use and other risk factors and duration of OCP use and other risk factors in the production of disease.

Cites

No record.

References

No record.

Cite

APA: Copy

KARIMIAN, S.F., & KHAYAT, E.. (2000). THE ROLE OF ORAL CONTRACEPTIVE (OCP) USE IN SYMPTOMATIC GALLSTONE DISEASE. TEHRAN UNIVERSITY MEDICAL JOURNAL (TUMJ), 58(1), 32-37. SID. https://sid.ir/paper/38115/en

Vancouver: Copy

KARIMIAN S.F., KHAYAT E.. THE ROLE OF ORAL CONTRACEPTIVE (OCP) USE IN SYMPTOMATIC GALLSTONE DISEASE. TEHRAN UNIVERSITY MEDICAL JOURNAL (TUMJ)[Internet]. 2000;58(1):32-37. Available from: https://sid.ir/paper/38115/en

IEEE: Copy

S.F. KARIMIAN, and E. KHAYAT, “THE ROLE OF ORAL CONTRACEPTIVE (OCP) USE IN SYMPTOMATIC GALLSTONE DISEASE,” TEHRAN UNIVERSITY MEDICAL JOURNAL (TUMJ), vol. 58, no. 1, pp. 32–37, 2000, [Online]. Available: https://sid.ir/paper/38115/en

Related Journal Papers